The FDA has even authorised a drug created with cannabidiol for that reason (Epidiolex). However the agency only suggests it for two unusual types of childhood epilepsy referred to as Lennox-Gastaut syndrome and Dravet syndrome.Offered these linked genetic and environmental vulnerabilities, more data from future, longitudinal investigation (studies